Beta Drugs Ltd

BETA29 Apr 2024

Pharmaceuticals

₹

-6.35 (-0.49%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Beta Drugs Ltd

Beta Drugs Ltd

Pharmaceuticals

BETA29 Apr 2024

₹

-6.35 (-0.49%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
30-Oct-2023	BC	1.To consider and approve the financial results for the period ended September 30, 2023 .2. To consider the Migration of the Equity shares of the Company from Emerge-SME Platform of National Stock Ex	07-Nov-2023
01-Sep-2023	BC	Beta Drugs Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 30, 2023 Beta Drugs Limited has informed the Exchange with copy of minutes of Annua	30-Sep-2023
01-Sep-2023	BC	Beta Drugs Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 23-Sep-2023 to 30-Sep-2023 for the purpose of Meeting.	23-Sep-2023
01-Sep-2023	BC	Beta Drugs Limited has informed the Exchange regarding Board meeting held on September 01, 2023.	01-Sep-2023
25-Apr-2023	BC	To consider and approve the financial results for the period ended March 31, 2023 BETA DRUGS LIMITEDhas informed the Exchange about Board Meeting to be held on 08-May-2023to inter-alia consider an	08-May-2023

No Rights has been declared by BETA

Book Closure

Record Date	Split Date	Purpose
07-Nov-2023	-	1.To consider and approve the financial results for the period ended September 30, 2023 .2. To consider the Migration of the Equity shares of the Company from Emerge-SME Platform of National Stock Ex
30-Sep-2023	-	Beta Drugs Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 30, 2023 Beta Drugs Limited has informed the Exchange with copy of minutes of Annua
23-Sep-2023	01 Jan'1900	Beta Drugs Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 23-Sep-2023 to 30-Sep-2023 for the purpose of Meeting.
01-Sep-2023	-	Beta Drugs Limited has informed the Exchange regarding Board meeting held on September 01, 2023.
08-May-2023	-	To consider and approve the financial results for the period ended March 31, 2023 BETA DRUGS LIMITEDhas informed the Exchange about Board Meeting to be held on 08-May-2023to inter-alia consider an

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Beta Drugs Ltd ₹1,300.00(-6.35/-0.49%)	1,300.00	-6.35	1,249.79	64.71	66.43	12.98
Lupin Ltd ₹1,637.45(+21.50/1.33%)	1,637.45	+21.50	74,626.80	131.02	36.21	3.87
Ipca Laboratories Ltd ₹1,334.00(-4.50/-0.34%)	1,334.00	-4.50	33,844.14	88.32	61.44	5.45
J B Chemicals & Pharmaceuticals Ltd ₹1,906.65(+41.60/2.23%)	1,906.65	+41.60	29,590.22	83.33	58.44	11.03
Sanofi India Ltd ₹8,277.50(+3.35/0.04%)	8,277.50	+3.35	19,063.08	52.52	32.30	18.78
IOL Chemicals & Pharmaceuticals Ltd ₹396.50(-3.00/-0.75%)	396.50	-3.00	2,327.67	-3.19	13.49	1.46

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	9.61	9.61	9.61	9.61	8.65	8.65
Reserves Total	86.64	67.85	53.80	46.83	31.95	24.23
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	96.25	77.46	63.41	56.44	40.60	32.88
Secured Loans	5.95	6.84	5.19	8.88	6.09	7.50
Unsecured Loans	0.00	0.00	0.00	0.03	1.79	0.00
Total Debt	5.95	6.84	5.19	8.91	7.88	7.50
Total Liabilities	102.20	84.30	68.60	65.35	48.48	40.38
APPLICATION OF FUNDS :
Gross Block	59.84	53.86	43.15	41.54	19.41	18.06
Less : Accumulated Depreciation	25.07	19.81	15.14	9.87	7.29	4.87
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	34.77	34.05	28.01	31.67	12.12	13.19
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	1.90	0.08	14.69	1.35
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	6.55	6.54	6.54	6.12	1.61	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	13.66	8.47	7.70	6.10	6.41	2.80
Sundry Debtors	43.59	31.35	20.81	20.91	17.33	14.44
Cash and Bank	17.79	15.58	8.27	4.16	2.92	11.91
Loans and Advances	9.95	7.35	6.78	6.00	4.73	3.17
Total Current Assets	85.00	62.76	43.55	37.17	31.39	32.32
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	26.31	22.22	15.23	15.42	15.01	8.30
Provisions	2.94	1.94	0.57	0.56	0.58	0.33
Total Current Liabilities	29.25	24.16	15.81	15.98	15.59	8.63
Net Current Assets	55.75	38.60	27.74	21.19	15.80	23.70
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.89	0.60	0.37	0.00	0.25	0.00
Deferred Tax Liability	0.00	0.00	0.00	0.03	0.15	0.15
Net Deferred Tax	0.89	0.60	0.37	-0.03	0.10	-0.15
Total Assets	97.96	79.80	64.56	59.03	44.32	38.08
Contingent Liabilities	0.74	0.00	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	15.58	8.27	4.16	2.92	11.91
Net Cash from Operating Activities	10.23	18.76	11.60	6.09	7.73
Net Cash Used In Investing Activities	-5.82	-12.72	-3.15	-14.33	-16.08
Net Cash Used In Financing Activities	-2.19	1.27	-4.34	9.48	-0.64
Net Inc./Dec In Cash And Cash Equivalents	2.21	7.31	4.10	1.24	-8.99
Cash And Cash Equivalents At End Of The Year	17.79	15.58	8.27	4.16	2.92

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

66.73%

FII Shareholding

0.32%

DII Shareholding

0.02%

Public Shareholding

32.92%

**Promoter pledged shareholding 66.73%

About Beta Drugs Ltd

Beta Drugs Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 1249.79 crores. It has reported a sales of Rs. 0 crores and a net profit of Rs. 0 crores for the quarter ended December 2018. The company management includes Rahul Batra, Balwant Singh.,Varun Batra,Rahul Batra,Manmohan Khanna,Rohit Parti,Rajni Brar,Seema Chopra,Ashutosh Shukla (Beta Drugs Ltd) among others.

Chairman

Rahul Batra

Registered office

Village Nandpur,,Baddi,Himachal Pradesh,174101

FAX :

Background

Incorporation Year2005

Face Value₹10

Market Lot1600

How to buy Beta Drugs Ltd shares on nse?

To buy Beta Drugs Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Beta Drugs Ltd share price today?

The Beta Drugs Ltd shares price on nse is Rs.1300 today.

What is the market cap of Beta Drugs Ltd shares on NSE ?

The company has a market capitalization of Rs.1249.79Cr

What is the PE & PB ratio of Beta Drugs Ltd shares ?

PE is 66.43 and PB is 12.98

What is the 52 Week High and Low of Beta Drugs Ltd shares?

Beta Drugs Ltd stock price high: Rs.1595 Beta Drugs Ltd stock price low: Rs.660